Cinnarizine
Back to searchMolecule Structure
Scientific Name
Cinnarizine
Description of the Drug
Cinnarizine is a drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00568
http://www.drugbank.ca/drugs/DB00568
Brand Name(s)
Marzine r.f., Mylan travel sickness, Stugeron, Stugeron fte
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Voltage-gated L-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2095229 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL44957 | |
DrugBank | DB00568 | |
PubChem: Thomson Pharma | 14803894 | |
PubChem | 1547484 | |
Mcule | MCULE-8383449065 | |
LINCS | LSM-42858 | |
Nikkaji | J39.649D | J2.572K |
PDBe | N90 | |
BindingDB | 50017657 | |
EPA CompTox Dashboard | DTXSID3022821 | |
DrugCentral | 654 | |
Brenda | 243490 | |
ChemicalBook | CB6384748 | |
Guide to Pharmacology | 9072 | |
rxnorm | CINNARIZINE | |
ChEBI | 31403 | |
ZINC | ZINC000019632891 |